Clinical predictors of treatment efficacy and a prognostic nomogram in patients with lung adenocarcinoma receiving immune checkpoint inhibitors: a retrospective study

BACKGROUND: At present, there is no accurate biomarker for immune checkpoint inhibitors (ICIs). Since the efficacy of ICIs is associated with a variety of indicators, establishing a model to predict its efficacy is more clinically significant and in line with clinical needs. METHODS: We collected an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Fang, Peng, Jin, Niu, Yanjie, Mao, Xiaowei, Zhao, Yizhuo, Jiang, Liyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641362/
https://www.ncbi.nlm.nih.gov/pubmed/36389292
http://dx.doi.org/10.21037/jtd-22-1270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641362/
https://www.ncbi.nlm.nih.gov/pubmed/36389292
http://dx.doi.org/10.21037/jtd-22-1270

Ejemplares similares